Filtros de búsqueda

Lista de obras de

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary interventio

artículo científico publicado en 2018

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial

artículo científico publicado en 2015

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

scientific article published on 17 March 2019

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial

scientific article published on 26 September 2019

Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial

artículo científico publicado en 2017

Apixaban with antiplatelet therapy after acute coronary syndrome

artículo científico publicado en 2011

Bivalirudin for patients with acute coronary syndromes

artículo científico publicado en 2006

Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial

artículo científico

Dabigatran versus warfarin in patients with atrial fibrillation

artículo científico publicado en 2009

Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe

artículo científico publicado en 2014

Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial

artículo científico publicado en 2019

Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention

Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus

artículo científico publicado en 2002

Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy

artículo científico publicado en 2017

Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial

artículo científico publicado en 2011

Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin

artículo científico publicado en 2002

Staphylococcus aureus alpha toxin mediates polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction

artículo científico publicado en 2002

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy

artículo científico publicado en 2015

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda